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Abstract 
Prenatal exposure to cocaine, as well as other drugs, has been linked with 
‘dysregulation’, usually defined as problems in arousal and/or behavioral regulation.  
This study was designed to describe the physiological basis of ‘dysregulation’ as a 
function of prenatal cocaine-polydrug exposure and term status.  Eight-week-old infants 
were selected because they are just developing the ability to modulate arousal.  One 
hundred eighteen infants (23 preterm control, 27 preterm drug-exposed, 29 fullterm 
control, 39 fullterm drug-exposed) completed a protocol during which heart rate (HR) 
and respiratory rate (RR) were measured.  Drug group differences were found in 
baseline, arousal (response to stress), and arousal modulation (recovery from stress).  
A hierarchical multiple regression analysis was conducted to determine the portion of 
variance attributable to postnatal caregiving environment, term status, and specific drug 
exposure. Term status accounted for significant variance in arousal (both RR and HR), 
and in arousal modulation (only RR).  Prenatal exposure to cocaine contributed a 
significant amount of unique variance in HR arousal, whereas tobacco contributed 
significantly to HR arousal modulation.  Prenatal drug exposure and preterm status 
contributed differently to ‘dysregulation’ as measured by physiological responses.  
 
Key words: cardiac system, respiratory system, cocaine, prenatal drug exposure, 
prematurity, tobacco 
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The effects of prenatal drug exposure, term status, and caregiving on  
arousal and arousal modulation in 8-week-old infants  
 Infants prenatally exposed to cocaine, and other drugs, are reported to exhibit 
‘dysregulation’ in arousal.  This ‘dysregulation’ in cocaine-exposed infants has been 
variously described as under-aroused (‘depressed’) or over-aroused (‘excitable’: Lester, 
Freier, & LaGasse, 1995), dysregulated in arousal-modulated attention (Karmel & 
Gardner, 1996), more excitable with poorer state regulation (Tronick, Frank, Cabral, 
Mirochnick, & Zuckerman, 1996), more irritable in response to novel stimulation (Mayes, 
Bornstein, Chawarska, & Granger, 1995), ‘disorganized’ in behavioral state (DiPietro, 
Suess, Wheeler. Smouse, & Newlin, 1995), having impaired regulation of arousal 
(Mayes, Bornstein, Chawarska, Haynes, & Granger, 1996), less emotionally responsive 
(Alessandri, Sullivan, Bendersky, & Lewis, 1995), and having more difficulty in self-
regulation (Chasnoff, Griffith, Freier, & Murray, 1992).  It is difficult to understand what 
these various dysfunctions in early regulatory ability may mean.  Do these terms 
describe the same or different problems?  Are the problems attributed to cocaine 
exposure based on dysfunctions of the same system?  What are the developmental 
consequences of these early dysfunctions?  The current study was designed to 
describe the physiological basis of arousal in order to better understand ‘dysregulation’ 
in cocaine-polydrug exposed infants. 
 Three indicators of the physiological basis of arousal were used: baseline, 
arousal (peak response) and arousal modulation (recovery from peak response). 
Baseline physiology was measured for two reasons.  First, baseline levels represent the 
set-points of the systems, which may differ in preterms and fullterms, and/or may differ 
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as a function of drug exposure.  Second, baseline values must be controlled when 
considering arousal responses, due to the Law of Initial Values (see Richards, 1980 for 
discussion).  The term “arousal” indicates the physiological changes from baseline to 
peak responses.  The term “arousal modulation” indicates recovery from the aroused 
state, and “good” arousal modulation is conceptualized as the return to baseline 
physiology at the end of the protocol.   
 It is important to identify those aspects of infants’ early regulatory ability that may 
be affected by prenatal drug exposure.  An assessment protocol was designed to be a 
moderately stressful situation for 8-week-old infants, and measured both Heart Rate 
(HR) and Respiratory Rate (RR). At the simplest level, arousal translates into increased 
HR and increased RR.  HR acceleration in response to a stimulus indicates stress or 
arousal, whereas HR cardiac deceleration in response to a stimulus is indicative of 
attention (e.g., Berg & Berg, 1979; Richards, 1991.  RR was included because of the 
reported links between (1) prenatal cocaine exposure and respiratory function (Brown, 
Bakeman, Coles, Sexson, & Demi, 1998: Silvestri, Long, Weese-Mayer, & Barkov, 
1991), (2) premature birth and respiratory problems, and (3) perinatal drug exposure 
(especially tobacco) and respiratory problems. In terms of RR, increased stress or 
arousal results in increases in RR, however, there is no comparable decrease in RR 
that indicates attention, although RR does vary by behavioral state, e.g., RR is lower in 
quiet sleep than REM sleep (Regalado, Schechtman, Del Angel, & Bean, 1996).  So, 
although the cardiac and respiratory systems are intricately linked, we expected to find 
that the systems reacted differently to moderate stress in 8-week-old infants who were 
prenatally exposed to drugs. 
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Arousal was studied in 8-week-old infants because basic physiological 
responses become organized around this age in typically developing infants.  
Throughout development, there are several distinct challenges faced by the infant and 
the caregiving environment.  One of the first challenges is establishing homeostasis that 
is, regulating arousal (Kopp, 1982; Riese, 1987).  When this challenge is met, infants 
can attend more effectively to external stimuli (‘initial regulation’: Greenspan & Lourie, 
1981; Anders, 1989).  In contrast, infants ‘at-risk’ may have difficulty in achieving this 
milestone. 
Despite reports that prenatal exposure to cocaine and other drugs affect arousal 
and arousal modulation, further research is warranted because the basis for these 
effects is not clear due to a number of factors associated with cocaine and other drug 
use which may affect developmental outcomes (see Lutiger, Graham, Einarsor, & 
Koren, 1991 for a meta-analysis of confounding factors commonly attributed to adverse 
effects of prenatal cocaine exposure).  These factors include 1); the indirect effects of 
polydrug use causing poor maternal health and prematurity 2) the direct effects of 
polydrug use on the fetus; and 3) the postnatal environment.  So, it is important to 
consider these factors which may influence arousal and arousal modulation in 
association with substance use. 
Maternal drug use has been shown to adversely affect the mothers’ health and 
prenatal care, and to increase the risk for preterm birth (Kliegman, Madura, Kiwi, 
Eisenberg, & Yamashita, 1994).  Each of these factors, especially preterm birth is 
associated with a number of negative developmental outcomes. It was decided to look 
at the effect of prenatal exposure to cocaine and other drugs on both fullterm and 
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preterm infants because few studies have included both in their samples and 
prematurity is known to influence arousal. Preterm status is a risk factor that may 
interact with prenatal drug exposure in an additive manner, suggesting that the preterm 
drug exposed infants would be the most ‘dysregulated’.  For example, 
cocaine/polydrug-exposed neonates exhibited increased irritability compared with 
controls, but more extreme irritability was found in infants that were both preterm and 
drug-exposed (i.e., Brown, Bakeman, Coles, Sexson, & Demi, 1998).  In contrast, 
preterm status might protect the fetus from the deleterious effects of longer exposure to 
drugs (compared to the length of exposure found in the fullterm infants).  In this case, it 
was expected that the preterm drug-exposed infants would be less dysregulated than 
fullterm drug-exposed (if drug exposure was more deleterious than prematurity).  In 
addition, postnatal caregiving environment may interact with prematurity: Premature 
infants raised in nonoptimal environments are particularly at risk for poor developmental 
outcomes (e.g., Alyward, Pfeiffer, Wright & Verhulst, 1989).  
Animal studies (reviewed in Spear, 1995) indicate that there are direct effects of 
prenatal exposure to cocaine on the central nervous system (e.g., cocaine blocks the 
re-uptake of neurotransmitters, dopamine, norepinephrine, and serotonin at the 
synapse), and on brain structures such as dendritic growth in the cerebellum (as 
reported by Willford, Hauser, & Barron, 1997).  It is less clear that there are any long-
term effects of cocaine on the cardiovascular system.  There is an indirect effect of 
cocaine exposure mediated by a decrease in uterine blood flow resulting in hypoxia in 
the fetus. In fact, there is some controversy about the teratogenic effects of cocaine 
since recent well-controlled studies in human infants find minimal effects (e.g., Coles, 
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Platzman, Smith, James, & Falek, 1992: Lester, Freier, & LaGasse, 1995).  Other drugs 
are often used in conjunction with cocaine, including alcohol, marijuana, and tobacco, 
and these drugs can also affect arousal.  Concern about the adverse effects of cocaine, 
in part, resulted from knowledge of negative direct effects of prenatal exposure to 
teratogens, such as alcohol.  Recent animal studies that combine exposure to cocaine 
and alcohol, for example, indicate that there are interactive effects on dendritic growth, 
at least in the cerebellum (e.g., Willford et al., 1997).  In addition, prenatal exposure to 
nicotine from maternal smoking has negative effects evident in the human newborn 
(e.g., an increased number of abnormal reflexes, Coles et al., 1992).  Thus, it is 
important to control for the effects of prenatal exposure to other drugs (by experimental 
design and/or by statistical means) because polydrug use is the rule for cocaine users. 
The postnatal caregiving environment has a strong influence on the infant and the 
infant’s developing self-regulatory system from a very early age.  The normal (or “good 
enough”) caregiving environment acts to facilitate the infant’s ability to self-regulate through 
the development of face-to-face interactions (Trevarthen, 1979, primary intersubjectivity) 
and, later, of joint attention (secondary intersubjectivity: Trevarthen & Hubley, 1978), 
achieving mutual regulation (e.g., Beeghly & Tronick, 1994).  It may be the case that 
consistent caregiver interactions are of primary importance in the integration of the social 
with the self-regulatory systems, which begins around 4 weeks of age (e.g., Zeifman, 
Delaney, & Blass, 1996).  In the early months of life this social scaffolding may be more 
salient than other regulatory systems for the infant (e.g., Coles, Bard, Platzman, & Lynch, 
1999). 
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Thus, the current study was designed to investigate the effects of prenatal 
exposure to cocaine (in addition to alcohol, tobacco, and marijuana) and postnatal 
caregiving environment (interactional characteristics, such as regularity of caregiving 
routines, and caregiver stability) on physiological arousal and arousal modulation in 
preterm and fullterm 8-week-old infants.  The hypotheses were that (1) Premature 
infants will exhibit higher arousal and poorer arousal modulation than fullterm infants; 
(2) Cocaine/polydrug-exposed infants will exhibit higher arousal and poorer arousal 
modulation than control infants; and (3) The effects of preterm birth and prenatal drug 
exposure will be additive, such that among the 4 groups, the preterm drug-exposed 
infants will be the most dysregulated. 
In most samples, women who abuse cocaine differ from non-users in a number 
of characteristics, such as age and social support networks (e.g., Woods, Behnke, 
Eyler, Conlon, & Wobie, 1995).  Moreover, it is typically the case that cocaine using 
mothers also use more alcohol, tobacco, and marijuana than non-cocaine using 
mothers.  Finally, the postnatal caregiving environment for infants of substance abusing 
mothers is often dramatically different from that of non-users in terms of daily schedules 
and routines, stability in caregivers, and paternal involvement in the family.  Any or all of 
these factors, in addition to prenatal exposure to cocaine, could be accounting for 
observed group differences in infant arousal and arousal modulation.  Therefore, the 
fourth aim of the study was to conduct a hierarchical multiple regression analysis to 
explain the unique contributions of drug exposure, term status, and postnatal caregiving 
environment to variance in arousal and arousal modulation, while controlling for 
maternal characteristics (such as age, income, and social support networks). 
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Methods 
Participants 
 The participants were 150 infants who began the 8-week protocol and their 
caregivers.  All of these infants were initially recruited in the hospital at birth.  Criteria for 
inclusion were 1) maternal age of at least 19 years; 2) no drug use other than cocaine, 
alcohol, tobacco, and marijuana; 3) adequate maternal health (e.g., no major medical 
conditions such as HIV infection, diabetes); 4) adequate infant health (e.g., no major 
infections, no major surgery, less than 30 days of oxygen); 5) planned bottle-feeding; 
and 6) English-speaking mothers (see Brown et al., 1998 for further details of the initial 
sample and the hospital sample from which the 8-week sample was drawn). Of the 150 
infants who were recruited at 8-weeks, and had at least one measurement of heart rate 
or respiratory rate, a total of 118 completed the exam.  Infants who finished and infants 
who did not finish the exam did not differ by drug group or by term status (see results on 
drop-outs). 
 Mothers were assigned to the drug group if they reported cocaine use during 
pregnancy, had a positive urine screen for cocaine, if their infants had a positive urine 
screen for cocaine, or if they reported alcohol use during pregnancy (> 2 oz AA/week).  
Mothers were assigned to the control group if none of these conditions were met.  
Medical records were used to determine drug use during pregnancy, and postpartum 
maternal and infant urine samples were analyzed for cocaine metabolites (enzyme-
multiplex immunoassay technique, EMIT assay).  Maternal self-reports consisted of 
Drug Checklist During Pregnancy (Coles, Brown, Smith, Platzman, Erickson, & Falek, 
1991) and the Addiction Severity Index (ASI: McClelland, Luborsky, Cacciola et al., 
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1985) administered either in the hospital and/or during the home visit within the first 30 
days.   Perinatal urine screens were collected from most mothers and infants (92% of 
the user group and 96% of the nonusers).  Most of the women with positive urine 
screens reported cocaine use (90%), and of the women in the user group with negative 
urine screens (34%), all reported cocaine or alcohol use during pregnancy.  In the 
nonuser group, all of the mothers reported no cocaine use, which was confirmed by 
urine screens in 96% of the cases (urine was not collected in the remaining 4% of the 
cases). 
 Term status of infants was determined by the Ballard scoring system (Ballard, 
Novak, & Driver, 1979: for details see Brown et al., 1998).  Sufficient information was 
obtained from infants’ medical records to determine that preterm infants were free of 
major health problems (82% scored less than 2 on the Neonatal Medical Index: Korner, 
Stevenson, Forrest, Constantinou, Dimiceli, & Brown, 1994).  Infants were classified as 
fullterm if they were at least 37 weeks GA at birth, or as preterm if they were between 
28 and 36 weeks.   
 At 8-weeks, preterm infants’ age was corrected to match the fullterms.  The 
average Ballard score for the fullterms was 39 weeks which was selected as the 
‘standard’.  The difference between the preterm infants’ age at birth and 39 weeks was 
added to the infants’ chronological age to arrive at the “corrected age” at which follow-
up testing should occur.  Infants were tested at 47 weeks conceptual age (8 weeks 
corrected age).  For example, a preterm infant born at 35 weeks conceptual age would 
be tested at 12 weeks chronological age (difference between 39 and 35 is 4 weeks, 
added to chronological age of 8 weeks to determine “corrected age”.) 
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Procedure 
The protocol was designed to provide a variety of stimulation to the infant which 
increased in complexity and intrusiveness (i.e., from listening to sounds to whole body 
manipulations).  The protocol employed the Bayley Scales of Infant Development (2nd 
Ed: BSID-II: Bayley, 1993) but it was slightly different from the clinical BSID-II in that: 1) 
the items were presented in a fixed order from single modality to multimodal in order to 
assess the infant’s response to increasingly complex stimuli, and 2) a few items from 
the first version (BSID: Bayley, 1969) were included.  The assessment lasted 
approximately 20 minutes and the examiner scored the infants' responses to obtain the 
typical BSID measures (i.e., the Mental Development Index (MDI) and the Motor 
Development Index (PDI) for each subject.   
 All infants were bottle-fed approximately 30 minutes before testing.  In this 
sample, breast-feeding was an exclusion criteria because exposure to drugs postnatally 
might affect arousal.  The test room was dimly lit.  Leads were attached to the infant’s 
thorax, and the infant was swaddled and placed in a prone position in a crib for 
approximately 10 minutes.  Then the infant was turned supine, and the head was 
positioned and propped midline.  The examiner soothed any infant who was fussy or 
crying prior to the baseline measurement using Brazelton & Nugent’s (1995) suggested 
ordering of consoling techniques (from showing face to picking up, rocking, swaddling, 
and giving a pacifier to the infant).  Physiology was measured at seven fixed and 
predetermined times.  After one minute of calm behavior, the baseline physiological 
measurement was taken.   The second physiological measurement coincided with the 
presentation of an inanimate auditory stimulus (a rattle). The third physiological 
Arousal and arousal modulation 12 
measurement was taken upon the presentation of an inanimate visual stimulus (a red 
ring). The fourth physiological measurement coincided with orientation to an animate 
visual and auditory stimulus (the examiner's face and voice).  The examiner talked to 
the baby for 1 minute and then assessed the infant’s reaction to the disappearance of 
the face, and the infant’s ability to follow a moving face.  One minute later (with no 
additional stimulation) the fifth physiological measurement was taken.  Assessment of 
the motor abilities of the infant was the next procedure.  The sixth physiological 
measurement was taken 1 minute after the completion of motor maneuvers in order to 
allow the infant to recover from the actual movement.  Thus, because the motor items 
were the last items of the BSID-II, the sixth measurement was 1 minute following the 
completion of the protocol.  The final measurement was 4 minutes later, a total of 5 
minutes after completion.  
Infant Physiological and Behavioral Measurements.  Heart rate (HR) in beats/minute 
and respiratory rate (RR) in respirations/minute were measured using a Hewlett 
Packard Cardiac Monitor (Model #788333) which provides a second by second display.  
Physiological and behavioral state measures were taken at seven fixed and 
predetermined times during the protocol (Figure 1).  Behavioral state was measured on 
a 7-point scale including states of 1) deep sleep, 2) light sleep, 3) drowsy, 4) quiet 
awake, 5) active awake, 6) fussy/crying, and 7) vigorous crying. 
------------------------------------------------ 
Insert Figure 1 about here 
------------------------------------------------ 
Each measurement (of HR, RR, and behavioral state) consisted of four point 
Arousal and arousal modulation 13 
samples, the first of which was taken with the initial presentation of the item, and then at 
15sec intervals thereafter for a total of 1 minute.  For the analyses presented in this 
article, the four values were averaged at each measurement for HR and RR.  For 
behavioral state, the equivalent ‘average’ was the predominant state within the one-
minute interval, i.e., the state that occurred for 3 or 4 of the measurement points.  If two 
states occurred equally often, then the most aroused state was used (i.e., rank ordering 
the states in arousal from asleep to awake to vigorous crying).  All coding of behavioral 
state and averaging of HR and RR was conducted by the first author who was blind to 
the drug group and term status of each subject and had not interacted with any of the 
infants. 
Assessment of Quality of Caregiving.  While the infant was tested, caregivers 
were interviewed by a staff member to assess the quality of care (using an in-house-
designed Structured Clinical Interview [SCI]: Coles, Platzman, Brown, Bard, & Lynch, 
1997).  Those aspects of the interview relevant to quality of caregiving (determined a 
priori) are listed in Table 1.  
------------------------------------------------ 
Insert Table 1 about here 
------------------------------------------------ 
Maternal Characteristics.  Maternal education, age, and income were obtained 
during interviews at the hospital and at a home visit within 30 days after birth (see 
above).  At the 8-week visit, the mother was interviewed regarding material resources, 
social support networks, and psychopathology.  
 The Family Resources Scale assessed material resources and consisted of 31 
items (Dunst & Leet, 1988).  The Social Support Scale consisted of 18 items (Dunst, 
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Trivette & Jenkins, 1988).  A single summary score was obtained for each scale, which 
was the number of items which the respondent assessed as adequate or more than 
adequate.  The SCL-90 is a 90-item self-report symptom inventory which assesses 
psychopathology (Derogatis, 1993).  It yields nine primary symptom dimensions (e.g., 
paranoia, depression) and three global indices.  The three global measures were highly 
correlated so one was chosen (the Global Severity Index: GSI) as a measure of 
maternal psychopathology. 
Data summary 
Infant physiologic and behavioral responses.  Two constructs, arousal and 
arousal modulation, were of interest.  Arousal was conceptualized in two ways: first, as 
highest level of arousal (i.e., the peak level of RR and HR) during the procedure and, 
second, as the timing of the peak level.  Peak HR (and RR) was determined simply as 
the highest one-minute average HR (RR) during the course of the test.  The second 
measurement of arousal was the period (of the 7 possible measurement periods) which 
contained the Peak HR (or Peak RR).  Arousal modulation was conceptualized as the 
infant’s ability to recover from an aroused state and was measured as the difference 
from baseline to the end of the protocol.  The final measurement, taken after 5 minutes 
after the completion of the test, was thought to reflect recovery from the moderate 
stress of the protocol with a return to baseline physiological levels.  For some analyses, 
the data were reduced from 7 measurements to 3 (baseline, peak, and end) in order to 
reflect the interest in arousal and arousal modulation.  Reducing the number of 
measurement periods also increased the number of subjects because there were some 
missing data points. 
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 Maternal Psychosocial Status.  A Factor Analysis (principal components 
factoring, varimax rotation) was performed to reduce the large number of variables 
collected that characterized maternal background to one or two conceptually distinct 
factors. Two factors emerged (eigen values 2.0 and 1.4, respectively), Resources 
(accounting for 25% of the variance and composed of Family Resources, Family 
Support, and Global Severity Index of the SCL-90 which loaded negatively) and SES 
(accounting for 17% of the variance and composed of Education, Income, and Maternal 
age).  Factor loadings for all included variables exceeded .50 and were standardized (to 
z-scores) and then averaged to form the two Factors (Resources and SES).  These two 
factors were used in the Regression analyses to describe Maternal Psychosocial 
Status. 
 Quality of Caregiving.  A Factor Analysis (principal components factoring, 
varimax rotation) was performed on the variables collected to assess Quality of 
caregiving. Two factors emerged accounting for 47% of the variance (with eigen values 
of 1.6 and 1.1, respectively): (1) Instability, which consisted of the Instability Cluster 
score from the SCI (Table 1 for the items assessed), whether the mother expected a 
lasting relationship with the father of the infant (loaded negatively), whether routine 
health care was planned, and whether the baby was planned (loaded negatively); and 
(2) Neglect, which consisted of involvement with Department of Family and Child 
Services (DFCS is the state child protection agency) and Caregiver Routine from the 
Structured Clinical Interview (SCI loaded negatively, see Table 1 for the items 
assessed).  Factor loadings for all variables exceed .47and were standardized then 
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averaged to form two factors (Instability and Neglect) used in the regression analyses to 
describe the postnatal caregiving environment (i.e., Quality of Caregiving). 
 Statistical Analyses.  Analyses with categorical data consisted of χ2 with some 
groupings collapsed to minimize the number of cells with expected frequencies less 
than 5.  Analyses with continuous data consisted of repeated measures ANOVA (begin, 
peak, end OR all 7 measurement periods) by term status (preterm, fullterm) and by drug 
group (drug-exposed versus control).  If drug group differences were found, then 
hierarchical multiple regression analyses were planned to investigate the contribution of 
each of four constructs to explain the drug group differences.  These constructs 
included Maternal Psychosocial Status, Quality of Caregiving, Term status (actual 
Ballard scores were used as a continuous measure), and Drug exposure (yes/no).  Due 
to significant skew in the distribution of amounts of drug used in the sample, the amount 
of use was re-coded to a dichotomous variable (specifically, cocaine exposure/absence, 
alcohol exposure/absence, tobacco exposure/absence, and marijuana 
exposure/absence: see Brown et al., 1998). The first two constructs were designed a 
priori but included only those items arrived at through factor analyses (see above).  The 
regression analyses were performed to ascertain whether exposure to specific drugs 
per se accounted for significant amounts of variance (after controlling for expected 
group differences in Maternal Psychosocial Status and Quality of Caregiving).  
Results 
Maternal Characteristics 
 Background characteristics and frequency of substance use are shown in Table 
2.  Mothers of drug-exposed infants were significantly older than mothers of control 
Arousal and arousal modulation 17 
infants (F(1,114)=15.39, p<.01). Fewer mothers in the drug group than the control group 
graduated from high school (χ2 (1)=6.40, p<.05).  Mothers in the drug group had more 
children than mothers in the control group (F(1, 79)= 7.64, p<.01). There were no drug 
group differences in race, income, or marital status.  There were no term effects, nor 
any drug group by term interactions on any of these variables. 
-------------------------------------------------------------- 
Insert TABLE 2 about here 
-------------------------------------------------------------- 
 Significant drug group effects were found in cocaine use (χ2 (1)=58.9, p<.01), 
alcohol use (F(1,107)=5.83, p<.05), tobacco use (F(1,113)=33.11, p<.01), and 
marijuana use (F(1,110)=11.25, p<.01).  However, there were no differences between 
the preterm and fullterm groups on any of these measures, nor any interactions of drug 
group by term status. 
 There were no differences in the reported emotional health of mothers of drug-
exposed infants and controls, nor between mothers of preterm and fullterms 
(Psychopathology measured by GSI of the SCL-90:Table 2).  Mothers in the drug group 
reported a lower level of adequate material resources (F(1,114)=4.45, p<.05) and less 
adequate sources of support (F(1,114)=4.96, p<.05) compared with mothers in the 
control group.  
Quality of caregiving 
 Significantly fewer drug-exposed infants were cared for by their biological 
mothers compared with control infants (Table 3).  Significantly fewer drug-exposed 
infants had a male caregiver present in the household than did control infants. 
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Significantly fewer mothers of drug-exposed infants received prenatal care (71%) 
compared with mothers of control infants (90%).  The drug-exposed infants had 
significantly more instability in caregiving compared with the control infants (as 
measured by the Instability cluster from the SCI: F(1,109)=6.92, p<.01).   There was 
significantly greater involvement by the drug group with DFCS compared with control 
infants (χ2 (1)= 9.67, p<.001).  There were no differences between the drug-exposed 
and control infants, or between preterm and fullterm infants in Caregiver Routine. 
-------------------------------------------------------------- 
Insert TABLE 3 about here 
-------------------------------------------------------------- 
Infant Characteristics 
 At birth, infants differed by term status and by drug group in some growth 
parameters (see Table 4). At 8-weeks corrected age, however, the only growth 
parameter that differed was length: the infants prenatally exposed to drugs were shorter 
than were the control infants (M=53.7 cm vs M=55.6 cm; F(1, 92)=9.13, p<.01).  Age at 
testing (M=56.6 days) was corrected for prematurity and did not differ by drug group nor 
term status.  There were no significant differences in the BSID-II scores by term status 
(MDI: F(1, 103)=0.52, ns. PDI: F(1,103)= 0.10, ns) or by drug group (MDI: 
F(1,103)=2.28, ns.  PDI: F(1,103)=0.58, ns).  
-------------------------------------------------------------- 
Insert TABLE 4 about here 
------------------------------------------------------------- 
Infant Physiological Responses 
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DROP-OUTS.   
As in most experiments with very young human infants, a proportion of the initial 
sample was unable to complete the test protocol.  One hundred and fifty infants began 
the physiological assessment but 21% of the sample (n=32) dropped out prior to the 
end of the paradigm – some cried excessively and inconsolably whereas others slept 
and could not be aroused. There was not differential drop-out, based either on term 
status (11/61 preterms and 21/89 fullterms dropped out: χ2 (2)=3.02, ns) or drug status 
(19/85 drug exposed and 13/65 controls dropped out: χ2 (2)= 3.09, ns).  There was an 
association of baseline HR with drop-out: Those who did not finish the exam had the 
lowest and most variable HR during the baseline period.  An additional 18% (n=27) 
exhibited some disruption during one or more periods but were able to finish the exam 
(recovers).  The majority (61%) of the 8-week-old infants were sampled at each of the 7 
periods (sustainers: n= 91). There were no differences between sustainers and 
recovers in beginning HR, peak HR, or end HR and so these latter two groups were 
collapsed.  There was no differential drop-out based on this new classification (i.e., 
drop-outs vs combined recovers and sustainers) on either drug group (χ2 (1)= 0.16, ns) 
or term status (χ2 (1)= 0.65, ns). 
BEHAVIORAL STATE 
 The majority of the sample (78%) started the exam in an awake, noncrying state 
(10% were sleeping or drowsy and 12% were crying).  A majority of the sample (75%) 
exhibited their Peak RR or HR response while crying (24% peaked with an awake state 
and 1% peaked with a drowsy state).  A majority of the sample was not crying at the 
end of the exam (34% crying, 38% awake, and 28% asleep or drowsy).  Preterms and 
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fullterms did not differ in behavioral state at any one of these periods, nor did drug 
exposed and control infants.  HR and behavioral state were significantly correlated 
throughout the examination periods (with correlations ranging from .23 in Auditory to .59 
at 1-min and 5-min Post).  Because these variables were significantly correlated and 
due to the continuous nature of HR and the categorical nature of behavioral state, the 
remainder of the analyses was conducted with HR as the dependent variable.  There 
were no significant correlations between behavioral state and RR. 
AROUSAL: Response to Stress 
Timing of arousal. 
HR changed significantly across the 7 periods (Figure 2: F(6, 48)=2.18, p<.05) 
indicating that the experimental paradigm was effective in eliciting a mild to moderate 
stress response.  Simple contrasts revealed that, compared to baseline levels, HR was 
significantly increased at the 5th period (after attention items), and at the 6th period (1-
min after completion of the protocol).  Comparison of peak level of arousal revealed that 
drug-exposed and control infants did not differ, and that preterm and fullterm infants did 
not differ in Peak HR.  However, there was a significant difference between groups in 
the pattern of response (i.e., timing): The drug-exposed infants peaked earlier in the 
exam than did the control infants (χ2 (4)=10.35, p<.05).  The preterm infants did not 
differ in timing compared with the fullterm infants.  However, the analysis of the four 
groups considered together revealed a significant interaction (Table 5: χ 2(9)=18.3, 
p<.05):  Most preterm infants exhibited their peak HR during baseline or during the first 
three attention periods (48% of the preterm drug and 39% of the preterm control 
groups) as did most of the fullterm drug group (31%).  Most of the fullterm controls 
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(50%), however, exhibited their peak HR during the final baseline period (5-min 
recovery). 
-------------------------------------------------------- 
Insert FIGURE 2 and TABLE 5 about here 
-------------------------------------------------------- 
Respiratory Rate (RR) 
There was a significant change in RR across the three periods, Beginning, Peak, 
and End (F(2, 113)=155.98, p<.001: within-subjects contrasts revealed a significant 
change from beginning to peak F(1, 114)=217.69, p<.001, but no difference between 
beginning and end levels).  There was a main effect of drug exposure. The group of 
infants prenatally exposed to drugs had a higher RR compared with the control infants 
across all three periods (Figure 2: F(1, 114)=4.50, p<.05).  There was a main effect of 
term status on RR.  Preterm infants had a higher RR compared with fullterm infants 
across all three periods (Figure 2: F(1,114)=7.25, p<.01).  In this repeated measures 
ANOVA, there were no interactions with change in RR.  This means that although 
baseline levels were different and peak levels were different, the RR change from 
baseline to peak response was not different by group or by term status.   
----------------------------------------------------------- 
Insert FIGURES 3 and 4 about here 
----------------------------------------------------------- 
Heart Rate (HR) 
  HR exhibited a significant change from beginning HR, to peak HR, to end HR 
(F(2,113)= 115.39, p<.001).  There were no main effects of term status or of drug 
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group.  Subsequent contrasts revealed that peak HR differed from baseline HR 
(F(1,114)=177.76, p<.001), but that baseline HR did not differ from end HR.  Moreover, 
the change in HR from beginning to peak was different for preterms and fullterms 
(within subject contrasts F(1, 114)=10.04, p<.01): Fullterms had a greater change 
(M=19.6) than did preterms (M=12.53).  There were no differences for drug-exposed 
compared with control infants in HR change from beginning to peak.   
AROUSAL MODULATION: Recovery from stress 
Arousal modulation was the change in responding across intervals either from 
baseline to end or from peak to end.  There was a significant three-way interaction of 
change in HR by term status by drug group (Figure 5: F(2, 113)=5.60, p<.01).  
Subsequent contrasts revealed that the effect was found in comparisons with the End 
period.  The fullterm control infants and the preterm drug-exposed infants showed the 
same pattern of response (higher end HR compared with beginning HR) which was 
different from the pattern shown by the fullterm drug-exposed infant and the preterm 
controls (a return in end HR to baseline HR levels). 
------------------------------------------------------------------- 
Insert FIGURE 5 about here 
------------------------------------------------------------------ 
INVESTIGATING DRUG GROUP DIFFERENCES: Hierarchical Multiple Regression 
The analyses described in this section were designed to investigate the 
contributions of the following constructs to the observed drug group differences entered 
into the analysis in the following 4 steps: (1) indirect effects of substance abuse acting 
through background Maternal Psychosocial Status (e.g., Resources, and SES see data 
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summary section for details) that might effect the developing fetus or infant; (2) indirect 
effects of substance abuse acting through the Quality of Caregiving (Instability and 
Neglect); (3) direct effects of preterm birth (Ballard score); and (4) direct effects of 
prenatal exposure to specific drugs (cocaine, alcohol, tobacco, and marijuana). Table 6 
lists the unique variance (deltaR2) at each step, the unstandardized partial regression 
coefficient (B) with standard error (SE), and the standardized partial regression 
coefficient (Beta) as each factor is entered in the model (with other variables in the set 
held constant). 
---------------------------------------------------------------- 
Insert Table 6 about here 
----------------------------------------------------------------- 
 BASELINE HR: BASELINE RR.   Regressions on baseline physiology did not 
reveal significant effects for any of these factors.   
AROUSAL (PEAK –BASELINE HR: PEAK RR).  Preterm status contributed 
significantly to HR Arousal (5.6% of variance accounted for: F(1,107)=6.42, p<.02).  
Prenatal exposure to cocaine contributed an additional significant amount of unique 
variance to HR arousal (4.0%: F(1,106)=4.75, p<.05). 
Preterm status contributed a significant proportion of unique variance to RR 
arousal  (6.4%: F(1,107)=7.49, p<.01). There was no significant effect of cocaine on RR 
arousal.  There were trends for contributions of alcohol (t=1.79, p=.076) and tobacco 
(t=-1.74, p=.085), but prenatal exposure to marijuana had no effect on RR arousal.   
AROUSAL MODULATION (END-BASELINE HR: END RR).  Prenatal exposure 
to cocaine contributed a marginally significant proportion of unique variance to HR 
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arousal modulation after controlling for differences in Maternal Psychosocial Status, 
Quality of Caregiving, and gestational age (2.7%: F(1,106)=3.05, p =.08).  Prenatal 
exposure to tobacco contributed significantly to HR arousal modulation (t=-2.04, p<.05).    
Gestational age contributed a significant amount of unique variance to RR 
arousal modulation (5.3%: F(1, 107)=6,01, p<.02).  There were no significant effects of 
specific drugs on RR arousal modulation. 
SUMMARY OF RESULTS 
The first hypothesis was that preterm infants would exhibit higher arousal and 
poorer arousal modulation than fullterm infants.  It was found that the physiological set-
points of the preterms and fullterms were different: preterms did have a higher baseline 
RR than fullterms.  But, after controlling for baseline RR, preterms did not have higher 
arousal (peak RR) than fullterms.  Additionally, there were no differences between 
preterm and fullterms in arousal modulation (end RR), after controlling for baseline RR.  
A different pattern of term effects were found in the cardiac system.  There were no 
difference in the set-point in HR: preterms and fullterms did not differ in baseline HR.  
There was a difference in arousal, after controlling for baseline HR, but surprisingly, 
fullterms exhibited higher arousal (peak HR) than preterms.  There were no differences 
between preterms and fullterms in arousal modulation but there was an interaction of 
term status and drug group in arousal modulation (see below). 
 The second hypothesis was that drug-exposed infants would have higher 
arousal and poorer arousal modulation than non-exposed infants.  In the respiratory 
system, differences were found in the set-point of the RR system: drug-exposed infants 
had a higher baseline RR than control infants.  However, there were no group 
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differences in arousal (peak RR) or arousal modulation (end RR), after controlling for 
baseline levels.  In the cardiac system, drug-exposed infants did not differ from control 
infants in baseline HR, or in arousal.  There were no differences between drug-exposed 
and control infants in HR arousal modulation but there was an interaction between drug 
exposure and term status (see below). 
The third hypothesis was that the effects of preterm status and drug exposure 
would be additive so that the preterm drug-exposed infants would exhibit the highest 
arousal and the poorest arousal modulation.  In the respiratory system, the effects of 
drug exposure and term status were independent (each contributed to higher baseline 
RR rates but they were not additive).  In the cardiac system, the effects were 
independent in arousal but interactive in arousal modulation.  In arousal modulation, 
preterm drug-exposed had poorer arousal modulation than did the preterm controls, but 
fullterm drug-exposed had better arousal modulation than did fullterm controls.  The 
level of recovery in HR was similar for the preterm drug-exposed and the fullterm 
control infants (these groups  did not return to baseline).  The fullterm drug-exposed 
and the preterm control infants exhibited “good” arousal  modulation (i.e., these groups 
did return to baseline).  Therefore, the hypothesis that preterm drug-exposed infants 
were the most dysregulated was rejected.  
The final hypothesis was that drug group differences could be accounted for by 
the contribution of postnatal caregiving environment, term status, and other drug 
exposure in addition to cocaine exposure.  In the respiratory system, there were no 
significant contributions of caregiving or drug exposure to arousal or arousal 
modulation, but term status contributed significantly to both arousal and arousal 
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modulation.  In the cardiac system, term status and exposure to cocaine contributed to 
arousal, and exposure to tobacco contributed to arousal modulation, after controlling for 
the nonsignificant contributions of maternal psychosocial characteristics, and postnatal 
caregiving environment. 
Discussion  
The physiological systems of arousal and arousal modulation are affected 
differently by prenatal drug exposure.  In the respiratory system of 8-week-olds, arousal 
was not affected by exposure to drugs after controlling for baseline levels, similar to the 
findings of Brown et al., (1996) for newborns.  Exposure to other drugs, alcohol and 
tobacco that co-occur with cocaine, more strongly affected arousal (RR).  HR arousal, in 
contrast, was significantly affected by exposure to cocaine, and only tobacco, among all 
the drugs, significantly affected HR arousal modulation.  Neither Brown et al., (1998) 
nor Tuboku-Metsger, O’Shea, Campbell, Hulse, Bugg, & Jones (1996) found drug group 
differences in baseline HR or HR arousal when infants were tested at birth, but Silvestri 
et al. (1996) found drug group differences in HR at 2-weeks (note that the effect was 
only in fullterm infants and that cocaine-exposed infants had lower HR than non-
exposed).  It appears that prematurity is the major contributor to RR arousal and RR 
arousal modulation, but both prematurity and prenatal exposure to drugs contribute to 
HR arousal and HR arousal modulation.  
Karmel & Gardner (1995), Regalado et al., (1995), and DiPietro et al., (1995) 
found cocaine exposed infants (4-week-olds, 2-week-olds, and newborns, respectively) 
exhibited higher arousal compared with non-exposed infants.  It is interesting, however, 
that all note that the arousal and arousal modulation patterns which were atypical in the 
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drug-exposed neonate were more “mature” patterns typical of older non-exposed 
infants (Karmel, Gardner, & Freedland, 1996).  This suggests that prenatal drug 
exposure may cause a dysregulation in the timing of what would otherwise be a 
developmentally appropriate response.  In the current study, there were no differences 
in peak levels of arousal but differences in timing, with drug-exposed infants exhibiting 
peak arousal earlier in the exam than non-exposed infants.  In this study, it is difficult to 
separate when the infants were most aroused, from what they were responding to with 
high levels of arousal.  Additional experiments are needed to test this hypothesis 
because the structure of the protocol used in this study does not allow us to disentangle 
the issues of timing from the type of stimuli.   
The control of the respiratory system and the cardiac system are closely linked; 
however, they are affected differently by preterm status and by prenatal drug exposure 
in 8-week-old infants.   In 8-week-old infants of the current study preterms had higher 
baseline RR than fullterm infants, which was also found by Lester et al., (1996) for 4-
week-old infants.  In newborns, however, Brown et al., (1998) did not find a significant 
difference in baseline RR for preterm and fullterms.  Perhaps, this is because both 
studies of older infants used corrected age (age corrected for prematurity) and the study 
of newborns tested the infants immediately after birth (for the fullterms but preterms 
were tested when medically stable which was a variable time after birth).  However, 
there were no significant correlations of baseline RR with gestational age at birth, nor 
any correlation of baseline RR at 8-weeks with basal RR at birth.  It is often the case 
that respiratory distress occurs in premature infants.  In this sample, however, only 
healthy preterms were selected and still the degree of prematurity accounted for 
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significant variance in arousal and arousal modulation in the respiratory system. 
Silvestri et al. (1996) also found different types of cocaine polydrug effects on the HR 
and respiratory functioning of preterm and fullterm infants.  These data suggest  that 
prenatal cocaine exposure increases the maturity of lung function in preterm infants 
(e.g., Hanlon-Lundberg, Williams, Rhim, Covert, Mittendorf, & Holt, 1996).  In contrast, 
prenatal cocaine exposure increases respiratory problems in fullterm infants (e.g., 
longer periods of apnea).  It is concluded, therefore, that prenatal drug exposure affects 
the homeostasis of fullterms differently than that of the preterms.   
The differences in baseline physiology are puzzling.  Drug group differences and 
term differences were found in baseline RR but not in baseline HR.  At 8-weeks, 
baseline RR was higher in the drug-exposed compared with the non-exposed whereas 
Regalado et al. (1996) did not find significant drug group differences in 2-week-old 
infants.  Gingras, Feibel, Dalley, & Muellenaer (1995) found drug group differences in 
the number of awakings from sleep (in infants from 3 to 7 days of age), and DiPietro et 
al. (1995) found a greater number of state changes in cocaine-exposed newborns.  
Unlike Regalado et al. (1996) findings that RR varied with sleep state, we did not find a 
correlation between behavioral states and RR.  In addition, there were no drug group 
differences in behavioral state at 8 weeks of age (most were typically awake during the 
entire protocol).  Although there were drug group differences in baseline RR, once 
differences in maternal psychosocial factors, in maternal caregiving, and in term status 
were controlled, drug exposure did not contribute significantly to baseline physiology.  A 
review of these studies suggest that cocaine may affect state organization involving 
sleep in neonates (specifically arousal from sleeping), whereas cocaine may affect 
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arousal from awake states by 8-weeks.  It is interesting to note that in a follow-up study 
of these infants when they were 24 months of age, significant drug group differences 
were found in sleeping problems, such as problems getting to sleep and restlessness 
during sleep, which are attributable to both caregiving (10.5% of the variance) and to 
prenatal cocaine exposure (3.5%: Coles et al, in preparation).  It appears that some of 
the differences in findings across studies can be explained by the age at which infants 
are assessed and their predominant behavioral state.  These are important variables, 
not only for infant assessments in general, but also when assessing drug exposure 
effects on arousal and arousal modulation. 
This study investigated arousal in 8-week-old infants who are just beginning to 
regulate states of arousal.  Thus, it is an interesting age to study the effects of drug 
exposure on dysregulation.  Previous studies of infants concentrated on newborns (birth 
through 30 days), or 3-5 month-old infants, who have mastered the challenges of 
regulating states and are facing new challenges (e.g., Kopp, 1982).  There are few, if 
any, studies of physiological responses as a function of cocaine exposure in older 
infants or toddlers.  Behaviorally based emotional responses to stressful situations 
appear blunted in cocaine-exposed infants at older ages (e.g., 4-8 months Bendersky, 
Alessandri, & Lewis, 1995).  It is not known whether there were accompanying 
physiological responses reflecting differential arousal (such as the low behavior-high 
cortisol stress response seen in Japanese babies, Lewis, Ramsey & Kawakami, 1993).  
Thus, it would be interesting to conduct a longitudinal study across the first year of life 
of physiological responses in infants prenatally exposed to cocaine.   
The protocol of the current study was moderately stressful, as indicated by 
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significant increases in both heart rate and respiratory rates, but there was not 
differential drop-out based on drug exposure.  In contrast, at 3-months of age, Mayes et 
al. (1995) found that more cocaine-exposed infants dropped-out compared with non-
exposed.  In addition, Mayes et al. (1996) found cocaine-exposed infants were more 
aroused to initial stimulus presentation than were non-exposed 3-month-olds.  Despite 
their increased arousal, the cocaine-exposed infants were not different from non-
exposed infants upon repeated presentation of the stimulus.  One possible 
interpretation of this effect is that cocaine-exposed infants experience greater arousal 
than non-exposed infants, and most (those who finished), by 3-months of age, have 
developed arousal modulation techniques to successfully deal with their increased 
arousal.  In the current study, the fullterm drug-exposed infants did exhibit arousal 
modulation (HR returned to baseline levels) and it was surprising that the fullterm 
control group did not exhibit arousal modulation.  It should be highlighted that, in this 
study, the fullterm control group did not modulate arousal, raising questions about our 
understanding of what is meant by ~good~ arousal modulation in the fullterm cocaine  
and preterm control infants.  There are areas of functioning that have been described as 
“better” or “more mature” in cocaine-exposed infants (e.g. faster visual processing, 
Jacobson, Jacobson, Sokol, Martier, & Chiodo, 1996) but we think that, in this case, it is 
the age-typical reliance on caregivers that is responsible for the fullterm control infants 
being most distressed by the post-test. 
It was predicted that quality of caregiving would significantly impact arousal and 
arousal modulation.  Specifically, the hypothesis was that the interactive effect of term 
status and drug group on HR arousal modulation occurred through the indirect pathway 
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of quality of caregiving.  In the immediate postnatal period, premature infants thrive with 
less stimulation compared with the optimal level for fullterm infants (e.g., Gorski, 1983).  
Mothers who abuse substances might engage in less stimulation of their infants than do 
non-substance abusing mothers (the strongest evidence for this statement is the 
increased incidence of infant mortality in the drug-exposed group compared with the 
non-exposed group, due to neglect rather than abuse: Coles, unpublished manuscript.  
Note, however, that when mothers are responsive they may be comparable to non-
substance using mothers in behavior, see for example, Bendersky & Lewis, 1998).  
Thus, the hypothesis was that this could be one pathway whereby the preterm drug-
exposed infants would exhibit homeostasis that is similar to the fullterm controls.  
However, the multiple regression analysis did not reveal a significant contribution of 
Quality of Caregiving to HR arousal modulation, so this hypothesis must be rejected.  A 
second speculation involves the causes for prematurity.  It could be that drug-exposed 
infants born prematurely differ from infants born prematurely for endogenous reasons.  
From animal studies, it is know that the most deleterious effects of prenatal cocaine 
exposure occur in the third trimester (reviewed by Spear, 1995).  Thus, it might be the 
case that arousal and arousal modulation in premature drug-exposed infants differs 
from that of fullterm drug-exposed infants due to a shorter duration of exposure to 
cocaine.    
It is possible to interpret the findings in both arousal and arousal modulation as 
drug group differences in reactivity to social stimuli.  The drug group exhibited peak 
arousal (HR) after orientation to the social stimulus.  In a study of 8-week-old infants, 
Coles et al. (1999) found drug-exposed infants exhibit HR accelerations to a social 
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stimulus but control infants exhibit HR decelerations indicative of focused attention to a 
social stimulus.  There were no drug group differences in HR patterns to nonsocial 
stimuli.  Both studies found that cocaine was significantly related to HR arousal. In 
contrast to the current study, however, Coles et al. found that the quality of caregiving 
accounted for an additional significant amount of the variance in HR arousal (i.e., 
response to social stimuli).  The differences in arousal modulation may relate to the 
reaction of a lack of social interaction: the fullterm control infants, among the four 
groups, exhibited their peak arousal (HR) in response to the absence of social 
stimulation (5 minutes after the cessation of the exam).  Both the preterm control infants 
and the fullterm drug-exposed infants were able to recover from stress when left alone 
for 5 minutes.  In the current study, neither arousal nor arousal modulation was related 
to postnatal caregiving.  More research is clearly needed to tease apart the 
mechanisms.  It is likely that the caregiving environment has an impact on the types of 
stimuli that infants find arousing (or interesting) and on the manner by which infants 
recover from stress.  In contrast, prematurity and prenatal drug exposure impact 
baseline physiology, and the levels of arousal and arousal modulation. 
Prenatal cocaine exposure may result in subtle differences in development. 
Cocaine appears to act earliest on endogenous neuroregulatory capacity, perhaps 
imparting physiological irritability (Brown et al., 1998; Lester et al., 1995) and increased 
arousal from sleep at birth (DiPietro et al.,1995; Gingras et al., 1995).  Cocaine and 
postnatal caregiving may already interact by 2-months of age, thereby altering 
neurophysiological modulation.  Recent research in the development of the opioid 
system suggests that social stimuli begin to be an integral part of the regulatory system 
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as early as 4 weeks of age (Zeifman et al., 1996), and opioid receptor binding is altered 
by cocaine (e.g., Spear, 1995).  So studies that report cocaine effects are often indirect, 
via pathways of maternal health or quality of caregiving (e.g., Black, Schuler, & Nair, 
1993: Vogel, 1997) are probably helping to explain ‘dysregulation’ in the sense of the 
integration of social supports with self-regulation.  By 3-months of age, the infant’s 
neurophysiological modulation has become integrated with the regulatory supports of 
the caregiving environment (e.g., Bigleow, 1997).  Neurophysiological modulation may 
lay the foundation for self-regulatory abilities during emotionally stressful situations later 
in life (Kopp, 1982).  It is likely that the combination of prenatal cocaine exposure 
(affecting physiological regulation) and postnatal environment (affecting the integration 
of social supports for regulation) leads to the reports of “dysregulation” in social and 
emotional behavior in older infants and children.    
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Table 1:  Items in the Routine and Instability Clusters from the Structured Interview 
used to quantify Quality of Caregiving 
 
 
Items in the Caregiver Routine Cluster    Score 
1. Number of Daily Activities fewer than average (M= 2) Yes=1 
2. Number of Bottles fewer than average (M=4.35)  Yes=1 
3. Number of Diaper Changes fewer than average (M=5) Yes=1 
4. Baby always held during feeding    No=1 
5. Caregiver recognizes “hungry “ cry    No=1 
6. Baby notices sounds      No=1 
7. Baby looks at things      No=1 
8. Family responds positively to baby’s cries   No=1 
9. Baby can be comforted easily     No=1 
10. Baby has learned new things     No=1 
 
 
 
 
Items in Parenting Instability Cluster    Score 
 
1.  Preparations made for baby prenatally   No=1 
2.  Baby has necessary supplies/equipment   No=1 
3.  Adult Male in household     No=1 
4.  Baby in ‘daycare’ more than 40 hours per week  Yes=1 
5.  Mother has help with baby     No=1 
6.  Baby has more than 2 regular caregivers   Yes=1 
7.  Baby separated from primary caregiver (> 48 hours) Yes=1 
8.  Baby fed significantly less than average (M=19.7oz) Yes=1 
9.  Baby sleeps significantly more or less than average Yes=1 
10.Respondent is biological mother, father, grandmother, 
      or foster parent       No=1 
11.If not living with mother, sees mother regularly  No=1 
12.Baby has own bed      No=1 
13.Baby has frequent falls/injuries    Yes=1 
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Table 2: Maternal characteristics (Mean + SD or % of group) and Drug use (n=118) 
         
        
Maternal Characteristics  Preterm Control 
(n = 23) 
 Preterm Drug 
(n = 27) 
 Fullterm Control 
(n = 29) 
 Fullterm Drug 
(n = 39) 
Maternal Age (yrs)**  26.6 (6.1)  31.0 (5.9)  26.4 (5.1)  29.6 (4.0) 
         
Education (at least   70%  52%  66%  38% 
     High School grad)*          
         
Income 
(percent<$300/mo)  
 52%  73%  66%  54% 
         
Marital Status  78%  96%  90%  90% 
(percent unmarried)         
         
Ethnicity (%African-Am)  96%  100%  97%  97% 
         
Parity (# prev. births)**  2.44 (1.2)  3.50 (2.01)  2.89 (1.4)  3.70 (1.3) 
         
Global Psychopathology  52.7 (11.2)  54.3 (11.9)  53.2 (9.7)  55.9 (10.6) 
     (GSI T score)         
         
Social Support*  4.9 (2.9)  3.1 (2.6)  4.3 (2.9)  3.8 (2.9) 
         
Family Resources*  20.4 (5.4)  17.6 (5.7)  18.9 (5.9)  17.2 (5.7) 
         
Reported Drug Use         
Cocaine** 
        
Daily Use  0%  15%  0%  23% 
Weekly Use  0%  27%  0%  38% 
Monthly Use  0%  19%  0%  13% 
 
Alcohol (oz AA/wk)*  0.02 (0.11)  3.75 (6.80)  0  5.17 (15.46) 
 
Tobacco  
(#cigarettes/wk)** 
 
 18.56 (44.50)  55.67(43.60)  7.17 (19.5)  62.80 (54.01) 
Marijuana (# joint/wk)** 
 
 
 0  0.5 (0.94)  0  0.16 (0.46) 
*p<.05  **p<.01         
 
Arousal and arousal modulation 44 
 
Table 3: Quality of Caregiving variables for drug-exposed and control groups. 
 
     Drug  Control Statistics  
Parenting Instability 
Instability Cluster*(M + SD) 2.87 +1.59 2.08 +1.37 F(1,109)=6.92, p<.01 
     Mom is primary caregiver* 77%  95%  χ2(1)=6.69, p<.01 
 Male caregiver present* 42%  62%  χ2(1)=4.44, p<.05  
 Received prenatal care* 75%  96%  χ2(1)=8.62, p<.01 
Lasting relationship with male* 52%  71%  χ2(1)=3.85, p<.05 
Baby was planned*      7%  31%  χ2(1)=9.20, p<.01 
 
Parental Neglect 
Routine Cluster (M+SD)  1.68+1.10 1.40 +1.18 F(1,109)=2.21, ns 
Protective Services (DFCS)* 17%     0%  χ2(1)=9.67, p<.01 
Thing baby has learned* (M) 2.33+1.2 3.03+1.49 F(1,109)=6.55, p<.05 
Types of daily activities* (M) 3.30+1.76 4.04+1.70 F(1,109)=4.55, p<.05 
 
* Drug group differences 
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Table 4: Infant characteristics at birth and at 8-week visit (N=118): Mean (and 
SD) 
At Birth  Preterm Control 
(n = 23) 
 Preterm Drug 
(n = 27) 
 Fullterm Control 
(n = 29) 
 Fullterm Drug 
(n = 39) 
Gestational age+  33.7  33.8  39.7  39.2 
 
 (1.8)  (2.0)  (1.3)  (1.2) 
 
        
Apgar 1min+  6.36  6.5  8.08  8.44 
  (2.34)  (2.21)  (1.47)  (1.80) 
         
Apgar 5min+  7.77  8.12  8.96  8.91 
  (1.34)  (1.33)  (0.20)  (0.30) 
         
Birthweight (gm)+ *  1830  1726  3213  2787 
  (350)  (370)  (504)  (538) 
         
Birth Length (cm)  42.95  43.64  50.00  47.3 
  (2.20)  (5.20)  (2.73)  (2.50) 
         
Head Circumference (cm)  29.72  30.25  33.81  32.69 
  (2.09)  (4.04)  (1.06)  (1.44) 
         
Sex (% female)  44%  41%  50%  49% 
         
At 8-weeks         
Corrected age (days)  58.65  56.04  55.08  57.89 
  (8.55)  (5.28)  (2.88)  (9.76) 
         
Length (cm) *  54.93  53.75  56.13  53.88 
  (2.88)  (3.12)  (2.85)  (2.57) 
         
Weight (gms)  4878  4724  4939  4898 
  (925)  (774)  (770)  (584) 
         
Head Circumference (cm)  39.10  38.00  38.18  38.39 
  (1.92)  (1.29)  (1.76)  (1.60) 
         
MDI (N=97)  93.57  93.26  94.96  90.41 
  (7.77)  (7.79)  (7.13)  (6.66) 
         
PDI (N=94)  95.2  95.61  97.56  94.27 
  (11.38)  (8.78)  (10.05)  (10.04) 
         
+Term Effect         
* Drug Effect         
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Table 5:  Significant relation between group and period of Peak Heart Rate:  
Number of subjects (and percentage within the group) that exhibited their Peak HR 
within each period. 
Peak Period     
 Preterm Drug Preterm Control Fullterm Drug Fullterm Control 
Attention* 13 (48%) 9 (39%) 12 (31%) 6 (21%) 
Post-Motor  6 (22%) 5 (22%) 10 (26%) 4 (14%) 
1-min Post  5 (18%) 5 (22%) 12 (31%) 5 (17%) 
5-min Post  3 (11%) 4 (17%) 5 (13%) 14 (48%) 
     
     
 
Note:  Attention is the sum of baseline and all three attention periods due to 
small expected frequencies. 
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Table 6: Results of Hierarchical Multiple Regressions on HR and RR arousal and arousal modulation. 
DeltaR2 B (SE) Beta DeltaR2 B (SE) Beta DeltaR2 B (SE) Beta
Maternal Psychosocial 0.029 0.015 0.005
Resources 1.91(1.62) 0.112 0.60 (1.67) 0.04 1.77 (2.48) 0.069
SES 2.37(2.09) 0.109 -2.73(2.15) -0.12 -1.11(3.19) -0.034
Quality of Care 0.019 0.002 0.002
Instability 1.16(1.80) 0.061 -0.18(1.87) -0.01 0.94(2.77) 0.033
Neglect 2.92(2.27) 0.128 -1.20(2.36) -0.05 1.04(3.50) 0.03
Gestational Age 0.016 0.056* 0.021
Cocaine (yes/no) 0.004 0.040* 0.027+
Other drugs 0.013 0.030 0.051
Alcohol (yes/no) 0.48(3.55) 0.017 2.00(3.51) 0.07 2.30(5.28) 0.054
Tobacco (yes/no) 2.39(3.60) 0.087 -6.68(3.56)+ -0.24 -10.91(5.35)* -0.26
Marijuana (yes/no) -4.55(4.09) -0.119 1.04(4.04) 0.03 9.40(6.09) 0.16
DeltaR2 B (SE) Beta DeltaR2 B (SE) Beta DeltaR2 B (SE) Beta
Maternal Psychosocial 0.025 0.004 0.001
Resources 0.70 (1.13) 0.059 -0.54(1.13) -0.047 0.25(1.17) 0.021
SES -1.81(1.45) -0.120 0.76(1.45) 0.051 0.12(1.50) 0.008
Quality of Care 0.020 0.016 0.005
Instability 0.81 (1.59) 0.052 1.09(1.25) 0.083 -0.42(1.30) -0.031
Neglect 1.28(1.26) 0.097 1.56(1.59) 0.099 1.05(1.65) 0.065
Gestational Age 0.000 0.064* 0.053*
Cocaine (yes/no) 0.008 0.018 0.006
Other drugs 0.014 0.047 0.022
Alcohol (yes/no) 2.19(2.46) 0.113 4.21(2.35)+ 0.22 0.29(2.50) 0.014
Tobacco (yes/no) -2.24(2.50) -0.118 -4.15(2.38)+ -0.22 2.69(2.54) 0.138
Marijuana (yes/no) 0.83(2.80) 0.032 0.96(2.71) 0.04 -3.87(2.89) -0.143
Delta R2 is unique variance at each step, B is unstandardized partial regression coefficient (with Standard Error), and 
Beta is standardized partial regression coefficient.
Note + indicates p<.10; * indicates p<.05; and ** indicates p<.01
Baseline HR Peak-Baseline HR End-Baseline HR
Baseline RR Peak RR End RR
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Captions 
Figure 1: Diagram of procedure for obtaining physiological measurements of 
Heart Rate and Respiratory Rate. 
Figure 2: Pattern of Heart Rate during protocol for drug-exposed and control 8-
week-old infants. 
Figure 3: Pattern of Respiratory Rate during protocol for drug-exposed and 
control 8-week-old infants. 
Figure 4: Beginning, Peak and End Respiratory Rate for drug group and control 
groups of 8-week-old infants: Significant main effect of group in repeated measures 
ANOVA. 
Figure 5: Beginning, Peak and End Respiratory Rate for preterm and fullterm 
infants: Significant main effect of term status in repeated measures ANOVA. 
Figure 6: Beginning, Peak, and End Heart Rate by group (drug, control) and term 
status (fullterm, preterm): Significant three way interaction of Change in Heart Rate by 
group by term status. 
